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1. INTRODUCTION 
We have reported [l-5] that the mitochondrial 
ATPase F1 is strongly and specifically inhibited by 
octahedral metal&chelates of bathophenanthro- 
line (4,7-diphenyl- 1, IO-phenanthroline, BPh) and 
that the inhibition is relieved by uncouplers of ox- 
idative phosphorylation. It was shown that the in- 
hibitor binds to the P-subunit of F1 and that the 
reversal of the inhibition by uncouplers involves a 
binding of the uncouplers to the inhibitory chel- 
ates, resulting in a catalytically active enzyme- 
inhibitor-uncoupler complex. Evidence was also 
obtained which indicated that this inhibition may 
occur generally with enzymes catalyzing the rever- 
sible hydrolysis of pyrophosphate bonds, and it 
was speculated that the inhibitory chelates may act 
by blocking a proton transfer between the active 
centers of these enzymes and the surrounding me- 
dium which may be essential for the catalysis [6]. 
[7], taking advantage of the fluorescence of this 
chelate. This paper is a brief report on the interac- 
tion of BP~JRu~+ with soluble F1. 
2. MATERIALS AND METHODS 
The above studies were performed mainly with 
the Fez+ trichelate of BPh (BPh3Fe2+), although 
it was shown that BPhjNiz+ and BPh3Ru2+ are 
equally efficient in bringing about an uncoupler- 
reversible inhibition of Fl-ATPase. Recently, we 
have extended these studies by using BPh3Ruz+ 
Mitochondrial F1 -ATPase was purified from 
beef heart mitochondria according to [8]. It had a 
specific activity of approximately 100 pm01 . 
min -1 . mg protein-l. The enzyme was stored at 
4°C in a 50% saturated (NH&S04 suspension 
containing 0.125 M sucrose, 5 mM Tris-S04, 
1 mM EDTA and 3 mM ATP (pH 7.6). Before use, 
an aliquot of the suspension was centrifuged, and 
the sediment was dissolved in 0.25 M sucrose, 
10 mM Tris-SO4 and 2 mM EDTA (pH 7.6). 
ATPase activity was assayed at 30°C in a 1 ml re- 
action mixture containing 25 mM Tris-AC, 30 mM 
KAc, 3 mM MgAc, 4 mM ATP, 15 mM PEP, 50 pg 
PK, 18 pg F1 and varying concentrations of 
BPh3R3+ and/or FCCP. The reaction was stop- 
ped after 1 min by addition of 50 ~1 100% TCA 
and the amount of Pi liberated was determined by 
the method of [9]. Molarity of F1 is given assuming 
a molecular weight of 360 000 and 100% purity. 
Abbreviations: BPh, bathophenanthroline (4,7-diphenyl- 
l,lO-phenanthroline); DNP, 2,4_dinitrophenol; FCCP, 
carbonyl cyanide p-trifluoromethoxyphenylhydrazone; 
1799, 2,6-dihydroxy- l,l, 1,7,7,7-hexafluoro-2,6-bis(tri- 
fluoromethyl)heptan-4-one; PEP, phosphoenolpyru- 
vate; PK, pyruvate kinase; TCA, trichloroacetic acid; 
BSA, bovine serum albumin. 
ESU particles were prepared from beef heart 
mitochondria by treatment of ‘EDTA particles’ 
[lo] with Sephadex and urea as in [ 111. 
Protein was determined by the method of Lowry 
et al. [ 121, using BSA as standard. 
BPhJRu2+ was obtained as a kind gift from Dr 
David Sigman, Department of Biological Chemis- 
try, University of California, Los Angeles, USA. 
Fluorescence measurements were made at 20°C 
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with an Aminco-Bowman spectrophotometer, with 
470 nm as excitation wavelength and 600 nm as 
emission wavelength, in a medium containing 50 
mM Tris-Ac (pH 7.5). 
3. RESULTS AND DISCUSSION 
The excitation spectrum of BPhjRuz+ in 50 mM 
Tris-Ac (pH 7.5) reveals two excitation maxima, 
at 440 and 470 nm respectively (tig.IA). These 
maxima are close to those in the visible adsorption 
spectrum, viz. 430 and 460 nm. The emission spec- 
trum shows a maximum at 600 nm, when 470 is 
used as excitation wavelength (tig.lB). Addition of 
Ft enhances the BPhJRu2+ fluorescence and this 
fluorescence enhancement is abolished by the un- 
coupler FCCP (fig.2). The effect of FCCP is dupli- 
cated by other uncouplers including 1799 and 
DNP. Also, in accordance with earlier findings 
showing a direct interaction between inhibitory 
bathophenanthroline chelates and uncouplers, 
FCCP abolishes the BPh3Ru2+ fluorescence in the 
absence of Ft. 
Titrations with Fl at a constant chelate con- 
centration shows a hyperbolic relationship be- 
tween the extent of fluorescence enhancement and 
the Ft concentration (tig.3A), with an extrapolated 
enhancement of 5.4-fold at infinite Ft concen- 
A 
Fig.1. Fluorescence excitation spectra (A) and emission 
spectra (B) of BPhjRu2+. 
1. medium 
2. medium + BPhjRu’+ 
3 medium + BPhjRu’* + Fl 
4 medium + BPhjRu’+ + FJ + FCCP 
excitation: 470 nm 
500 600 700 nm 
Fig.2. Effect of Ft, in the absence and presence of 
FCCP, on the fluorescence of BPh3Ru2+. 
tration (fig.3B). In fig.4 it can be seen that the 
fluorescence-enhancement of BPhJRuz+ is para- 
llel to the inhibition of the ATPase activity, and 
that the fluorescence-enhancement is abolished by 
FCCP along with the reversal of the inhibition. 
The Fl-induced BPh3Ru2+ fluorescence is vir- 
tually independent of the pH of the medium in the 
range of 5-9. As expected, the fluorescence-en- 
hancement, decreases when the temperature of the 
medium is increased. 
ATP, ADP or ADP-Mg, at a concentration of 4 
mM, does not effect the enhancement of BPh3- 
Ru2+ fluorescence by Ft. Nor does the ATPase in- 
hibitor protein used at concentrations totally in- 
hibiting the ATPase activity, influence the Ft- 
induced BPh3Ru2+ fluorescence-enhancement. 
Figure 5 shows that cold-inactivation of Fl re- 
sults in an increase of the fluorescence-enhance- 
ment of BPh3Ru2+ by Ft, probably due to the fact 
that Ft dissociates in the cold and more binding 
sites of the enzyme become exposed to the chelate. 
It can also be seen in fig.5 that inhibition of Ft by 
photooxidation in the presence of Rose Bengal 
1131, results in a decrease of the maximal 
BPh3Ru2+ fluorescence-enhancement by Ft. 
Rebinding of Ft to ESU particles causes a 
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Fig.3. Relationship between the extent of BPh3Ru 2+ fluorescence-enhancement and Fl concentration. 
quenching of the Fl-induced BPhjRu*+ fluor- 
escence-enhancement, suggesting that the hydro- 
phobic chelate binds unspecificially to the mem- 
brane. The effect is consistent with earlier results 
[2] showing that membrane-bound F1, compared 
to the soluble enzyme, needs much higher chelate 
concentrations for maximal inhibition. 
The Fl-induced enhancement of BPhjRu*+ 
fluorescence proved not to be specific, other pro- 
teins, e.g., BSA, insulin and yeast PPiase - show- 
ing the same effect. BSA is just as effective as FI in 
enhancing the BPh3Ru *+ fluorescence, while yeast 
Pease is slightly more effective than F1 and in- 
sulin slightly less. Also in those cases uncouplers, 
such as FCCP, abolish the fluorescence enhance- 
ment. 
Scatchard plot representation of titrations with 
BPh3Ru*+ at constant F1 concentrations hows a 
non-linear relationship (fig.6), probably due to the 
strong association between BPh3Ru*+ and F1 and 
some unspecific binding of the chelate to the en- 
zyme at high chelate concentrations. Not taking 
into account the points at the lowest and the high- 
est chelate concentrations, each mol of F1 could be 
extrapolated to bind approximately 3 mol of 
BPhjRu* + . 
Titrations with F1 at constant BPhjRu*+ con- 
centrations show that half-maximal fluorescence 
enhancement is reached at a molar ratio of 
BPhjRu*+:Fl of 1.5 (fig.3A) indicating that F1 at 
maximal fluorescence enhancement binds 3 mol 
BPhjFe*+ /mol F1. 
These data are in good agreement with the re- 
sults [4] obtained with the Fe* + -chelate, showing 
the formation of an enzymically inactive complex 
between F1 and BPh3Ru*+, containing 3 mol 
BPhjF&+ /mol F1. 
It thus appears that BPhjRu*+ binds with high 
affinity to the same site of F1 as earlier concluded 
for BPh3Fe*+ [5], i.e., to the catalytic center of the 
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Fig.4. Correlation between the enhancement of BPh3Ru 2+ fluorescence by Ft and the inhibition and reactivation of 
ATPase activity by BPhjRu*+ and FCCP, respectively. 
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Fig.5. Effects of cold-inactivated Ft and of Ft photo- 
oxidized in the presence of Rose Bengal on the fluor- 
escence of BPh3Ru2+. Cold-inactivation: Ft at a protein 
concentration of 4 mg/ml was incubated for 6 h at 0°C 
(- 1% activity left). Photooxidation: Ft at a protein con- 
centration of 2 mg/ml, was incubated for 0.5 h in the 
presence of 10 PM Rose Bengal, in a small test tube im- 
mersed in a large volume of water kept at room tem- 
perature. The sample was illuminated with a 250 W 
slide projector during incubation ( - 1% activity left). 
80 
Volume 145, number 1 FEBS LETTERS August 1982 
0.0 a2 
BE3R”2+b_j ()IMl 
0.3 
Fig.6. Scatchard plot representation of titration with 
BPh3Ru2+ at constant Ft concentration. 
enzyme located on the b-subunit. Attempts to 
provide direct evidence for this conclusion, using 
the isolated /&subunit, are in progress. By virtue of 
its fluorescence, BPh3Ru2+ may seem as a valu- 
able probe for Fr and its catalytic subunit. 
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